208 related articles for article (PubMed ID: 9600601)
1. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy.
Gabriel JM; Erne B; Bernasconi L; Tosi C; Probst A; Landmann L; Steck AJ
Acta Neuropathol; 1998 May; 95(5):540-6. PubMed ID: 9600601
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.
Kawagashira Y; Koike H; Takahashi M; Ohyama K; Iijima M; Katsuno M; Niwa JI; Doyu M; Sobue G
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1303-1312. PubMed ID: 32856086
[TBL] [Abstract][Full Text] [Related]
3. Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy.
Kawagashira Y; Koike H; Tomita M; Morozumi S; Iijima M; Nakamura T; Katsuno M; Tanaka F; Sobue G
J Neuropathol Exp Neurol; 2010 Nov; 69(11):1143-57. PubMed ID: 20940626
[TBL] [Abstract][Full Text] [Related]
4. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening.
Ritz MF; Erne B; Ferracin F; Vital A; Vital C; Steck AJ
Muscle Nerve; 1999 Aug; 22(8):1030-7. PubMed ID: 10417783
[TBL] [Abstract][Full Text] [Related]
5. Microheterogeneity of anti-myelin-associated glycoprotein antibodies.
Fluri F; Ferracin F; Erne B; Steck AJ
J Neurol Sci; 2003 Mar; 207(1-2):43-9. PubMed ID: 12614930
[TBL] [Abstract][Full Text] [Related]
6. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
Lombardi R; Erne B; Lauria G; Pareyson D; Borgna M; Morbin M; Arnold A; Czaplinski A; Fuhr P; Schaeren-Wiemers N; Steck AJ
Ann Neurol; 2005 Feb; 57(2):180-7. PubMed ID: 15668968
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
[TBL] [Abstract][Full Text] [Related]
8. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy.
Gabriel JM; Erne B; Miescher GC; Miller SL; Vital A; Vital C; Steck AJ
Brain; 1996 Jun; 119 ( Pt 3)():775-87. PubMed ID: 8673490
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human nerve basal lamina for their binding properties of anti-MAG antibodies.
Sollberger M; Erne B; Sansano S; Steck AJ; Schaeren-Wiemers N
J Neurocytol; 2002 Jan; 31(1):5-14. PubMed ID: 12652083
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes at paranodes in IgM paraproteinaemic neuropathy.
Jacobs JM
Microsc Res Tech; 1996 Aug; 34(6):544-53. PubMed ID: 8842023
[TBL] [Abstract][Full Text] [Related]
11. Focal myelin swellings and tomacula in anti-MAG IgM paraproteinaemic neuropathy: novel teased nerve fiber studies.
Cai Z; Cash K; Swift J; Sutton-Smith P; Robinson M; Thompson PD; Blumbergs PC
J Peripher Nerv Syst; 2001 Jun; 6(2):95-101. PubMed ID: 11446389
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal IgM gammopathy with anti-myelin associated glycoprotein (MAG) activity and polyneuropathy. A study of three cases.
Sindic CJ; Boucquey D; Bisteau M; Laloux P; Brucher JM; Laterre C
Acta Neurol Belg; 1989; 89(5):331-45. PubMed ID: 2483599
[TBL] [Abstract][Full Text] [Related]
13. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia.
Weiss MD; Dalakas MC; Lauter CJ; Willison HJ; Quarles RH
J Neuroimmunol; 1999 Mar; 95(1-2):174-84. PubMed ID: 10229128
[TBL] [Abstract][Full Text] [Related]
14. The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids.
Freddo L; Ariga T; Saito M; Macala LC; Yu RK; Latov N
Neurology; 1985 Oct; 35(10):1420-4. PubMed ID: 2412183
[TBL] [Abstract][Full Text] [Related]
15. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody.
Kawagashira Y; Koike H; Ohyama K; Hashimoto R; Iijima M; Adachi H; Katsuno M; Chapman M; Lunn M; Sobue G
J Neurol Sci; 2015 Jan; 348(1-2):67-73. PubMed ID: 25467141
[TBL] [Abstract][Full Text] [Related]
16. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
17. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients.
Vital A; Vital C; Julien J; Baquey A; Steck AJ
Acta Neuropathol; 1989; 79(2):160-7. PubMed ID: 2480693
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
20. Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and neuropathy with components of neural tissues: evidence for interaction with more than one epitope.
Lieberman F; Marton LS; Stefansson K
Acta Neuropathol; 1985; 68(3):196-200. PubMed ID: 2417441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
